🔎 Trials Near Me

Akèy › Kansè Ipofaringe › North Carolina

Etid klinik pou Kansè Ipofaringe nan North Carolina

5 etid pou Kansè Ipofaringe ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Margaret R Pardee Memorial Hospital, Hendersonville
  • FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06589804

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Southeastern Medical Oncology Center-Clinton, Clinton
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  • Atrium Health Stanly/LCI-Albemarle, Albemarle
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • Atrium Health Pineville/LCI-Pineville, Charlotte
  • ak 9 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06532279

Integrated Cancer Repository for Cancer Research

  • Cape Fear Valley Health System, Fayetteville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.